Sildenafil vs Vardenafil
Sildenafil and vardenafil are short-acting PDE5 inhibitors used for erectile dysfunction. Both have a ~4–6 hour window of effect; vardenafil has slightly higher PDE5 selectivity but the clinical difference is modest. Tadalafil is the modern default for most candidates due to a longer window.
Sildenafil is appropriate for on-demand use when a short-window PDE5 inhibitor is preferred.
Vardenafil is appropriate in select cases of sildenafil intolerance and is not currently in the oMeds formulary.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Is one more effective?
At appropriate doses, response rates are comparable for the same candidate.
Is tadalafil usually better?
For many candidates, tadalafil's longer window and daily-dose option are preferred — that is the provider-reviewed default.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment